Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo — challenges and prospects

Due to the inability of classical chemotherapeutic agents to exclusively target tumor cells, these treatments are associated with severe toxicity profiles. Thus, long-circulating liposomes have been developed in the past to enhance accumulation in tumor tissue by passive targeting. Accordingly, comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakoby, Judith, Beuschlein, Felix, Mentz, Susanne, Hantel, Constanze, Süss, Regine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791260/
https://www.ncbi.nlm.nih.gov/pubmed/26497207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791260/
https://www.ncbi.nlm.nih.gov/pubmed/26497207

Ejemplares similares